report here polyclonal stimulation of resting B cells by T cell lines, by T cells cloned from such lines, and by cloned T cell hybridomas. T cells stimulated by antigen and antigen-presenting cells (APC) of the appropriate MHC type were capable of activating essentially all resting B cells to enter G~ phase in the absence of antigens for which the B cells were specific. A large fraction (~35%) of these cells entered S phase and substantial amounts of antibody were secreted. This polyclonai T cell stimulation of resting B cells was found to be MHC-unrestricted at the level of B cell-T cell interaction. It appears to represent a mechanism through which resting B cells may be activated by the action of T cells without occupancy of mIg and without cognate MHC-restricted T cell-B cell interactions.
Materials and Methods
Reagents. Goat anti-tt antibodies were purified by positive and negative affinity chromatography procedures as described previously (8) . GAT (poly-[Glu~°Ala3°Tyrl°]n) was purchased from Vega Biochemicals, Tucson, AZ, and pigeon cytochrome c was purchased from Sigma Chemical Co., St. Louis, MO, purified over carboxymethyl cellulose as previously described (18) and generously provided to us by Dr. Lawrence Samelson of this laboratory.
Mice. BI0 MHC-congenic strains of mice were bred as described (19) and were generally 2-6 months of age at time of use. BlO.xid mice were obtained from Dr. Carl Hansen, NIH. These mice were derived from B10.ScN mice, a lipopolysaccharide (LPS) unresponsive strain, into which the X chromosome from CBA/N mice was introduced as previously described (20) .
Cell Preparations. Spleen cells were incubated with monoclonal anti-Thy-l.2 (New England Nuclear, Boston, MA), monoclonal anti-Lyt-1 (53.7.3) and monoclonal antiLyt-2 (53.6.7) (21) on ice for 30-45 rain, centrifuged, resuspended in guinea pig complement (1:4 dilution; Flow Laboratories, Rockviile, MD) containing the monoclonal mouse anti-rat kappa chain antibody MAR 18.5 (22) , which increases the cytotoxicity of the antiLyt-1 and anti-Lyt-2 reagents, and incubated at 37°C for 30 min. Cells prepared in this way completely lacked proliferative Con A or mixed leukocyte responses. Following T cell depletion, spleen cells were fractionated on a Percoll density gradient as described (23) . The low density fraction (density <1.062 g/mi) was previously found to be enriched for macrophages (as assessed by latex bead phagocytosis) and for radioresistant APC. The high density fraction (density between 1.074 and 1.086 g/ml) was >80% mIg÷-celis and these were shown to be resting B cells by several criteria (23) . Except where specified, this high density fraction from the Percoll gradient was used and is referred to as "B cells." For some experiments, B cells were additionally purified by passage through columns containing Sephadex G- 10 (24) or passage through such columns followed by purification by adherence to and recovery from anti-#-coated petri plates (Corning 100-mm tissue culture-treated plates, coated with 10 ug/ml of affinity-purified goat anti-t~, 7 ml per plate) (25, 26) . Flow microfluorometric analysis of these populations indicated that after passage over a column of Sephadex G-10, 95% of the cells were mIg+; after recovery from anti-~-coated plates >99% of the cells were mIg ÷.
Long-term T Cells and Hybridomas. The T cell lines were grown as described in detail elsewhere (27, 28) . The T cell hybridomas used in this study have been previously reported (29) . Interleukin 2 (IL-2) secretion by the hybridomas was tested to ensure that the cells had not lost specificity after recovery from liquid nitrogen storage.
Tissue Culture and Analysis. Cells were cultured in Iscove's/F12 medium (30) with 10% fetal bovine serum. Generally, 2 × 105 B cells were cultured with ~2 x 104 T cells from T cell lines or with 1 x 105 hybridoma T cell in 96-well flat-bottom plates (Costar #3596) in duplicate. The T cells were irradiated sufficiently to reduce their proliferation and incorporation of [SH] thymidine to insignificant levels: for 11.4 T cells, 2,000 rads, for the T cell hybridomas, 10,000 rads, for other T cell clones, 3,300 rads. For Coulter counter (Coulter Electronics, Inc., Hialeah, FL) analysis of cell size, cells were harvested ~24 h after the initiation of the culture and analyzed as described previously (23) . For proliferation assays, 1 #Ci of [SH]thymidine was added to the cultures at 24 h after the start of culture and the incorporation of radioactivity was measured by collecting the cells, after 42-48 h of culture, with an automated harvester (Ph.D. Harvester, Cambridge Technology, Cambridge, MA) and counting the filters in a liquid scintillation counter. The period of time chosen for the incorporation of thymidine corresponds closely to the first round of replication of resting B cells stimulated with anti-# antibody (23) . Similar results were obtained in several experiments with either a 4-h pulse of thymidine on day 2 or a longer pulse on day 3.
[SH]Thymidine incorporation decreased considerably by day 4. Cell cycle analysis by propidium iodide staining of intact nuclei from hypotonically lysed cells was performed as described (23) except that a FACS 2 (Bectin-Dickinson, Mountain View, CA) was used to measure fluorescence of individual nuclei. The cell population was divided into cells in Go or G1 phases (diploid amounts of DNA), cells in G~ or M phases (tetrapioid amounts of DNA) and cells in S phase (content of DNA between diploid and tetraploid amounts). Colcemid (25 ng/ml) was added at 24 h of culture to prevent cells from completing M phase, thus ensuring that only cells entering S phase for the first time would be counted. IgM secretion was measured after 4 d of culture by an ELISA method (31) using goat anti-# (50 #g/ml) to coat flat-bottom tissue culture plates (Costar #3596), and developing with Biotinylated-Bet 2 (a monoclonal rat anti-mouse IgM [32] ) and avidinhorseradish peroxidase (Vector Laboratories, Inc., Burlingame, CA). Optical density of the wells was measured with a Dynatech plate reader. Standard curves with known amounts of an IgM myeloma protein were used to convert absorbance into concentration of IgM.
Results

Antigen-stimulated T Cell Lines Can Activate Resting B Cells.
Resting B cells were prepared from mouse spleen cells by treatment with monoclonal antibodies to T cell antigens and complement and by separation of the remaining cells by Percoll density gradient centrifugation. The most dense cells collected (>1.074 g/ml) have a median volume of 110 ums and are quite homogeneous in size. When resting B cells from B10.A mice were cultured with the syngeneic cloned B10.A T cell line, 11.4, and with GAT (100 #g/ml), the antigen for which 11.4 T cells are specific, a prompt and dramatic increase in cell volume occurred. By 21 h, virtually all of the cultured B cells had increased in size, typically attaining a mean cell volume of ~200 #m s in the presence of 1/10 as many T cells as B cells (Fig. 1 ). This size enlargement, which appears to reflect entry of Go cells into the G1 phase of the cell cycle (23) CELL VOLUME (~M a) (Table IV) . This was assessed by measuring the amount of IgM in the supernatant on day 4 of such cultures. Maximal IgM secretion was obtained in the presence of l0 s 11.4 T cells, which is far less than the number of 11.4 T cells that elicited maximal proliferation of B10.A B cells (see below). The failure to observe significant amounts of IgM secretion when numbers of 11.4 T cells optimal for B cell proliferation were used might represent a depletion of nutrients from culture since the degree of thymidine incorporation on day 4, the day when IgM synthesis was measured, was much less than at days 2 or 3. Alternatively, it may reflect an inability of rapidly proliferating cells to differentiate.
It is very unlikely that the activation of resting B cells in these cultures and their entry into S phase depends upon the presence of antigen(s) capable of binding to their mIg receptors, since virtually all the resting cells enter G1 phase and a considerable proportion enter S phase. It can hardly be expected that antigens complementary to receptors of all B cells are present in these cultures. way was not a unique property of 11.4 T cells, but rather was found to be a general property of antigen-specific T cell clones that could stimulate proliferation of syngeneic B cells. Experiments with other B10.A T cell clones are shown in Table III (34) . We tested the ability of xid B cells to proliferate when co-cultured with 11.4 T cells and GAT, both when these cells bore the A~:A~-restriction element and when they lacked it. B cells from (CBA/N X DBA/ 2)F1 male mice, which have the xid-determined defect and express A~:A~, showed excellent [3H]thymidine incorporation in response to 11.4 T cells and GAT (Table V) . These responses were greater than those stimulated by LPS and were not further enhanced by addition of 1,000-rad irradiated B10.A B cells. Although (Table V) . The meager response of the BlO.xid B cells to LPS is, at least in part, due to the fact that they are derived from the LPS-unresponsive strain C57BL/10 ScN. The control mice, C57BL/10 SgSn, are normally responsive to LPS.
Stimulation of Resting B Cells Does Not Require That They Participate in MHC-
These results indicate that B cells from xid mice are competent to stimulate 11.4 T cells in the presence of GAT and capable of being recruited, in an MHCunrestricted manner, to enter S phase.
Anti-IgM Antibodies Synergize with 11.4 T Cells in B Cell
Activation. Thus far we have shown that essentially all B10.A B cells will enter the GI phase of the cell cycle in the presence of 11.4 T cells and GAT. Antigen(s) capable of binding to the B cell's mIg do not appear to be required for this activation. Similarly, many of these B cells also enter S phase in such cultures. We have previously shown that low concentrations of anti-# (1 or 2 #g/ml) cause virtually all resting B cells to enter Ga phase but very few to enter S phase (9) . Some of these Gl B cells enter S phase in the presence of BSF-pl (10, unpublished observations).
We next examined the effect of addition of 2 #g/ml of anti-# to cultures containing B 10.A B cells, 11.4 T cells, and GAT (Table II) (Fig. 4) . In contrast, 11.4 T cells stimulated either with 1,000-rad irradiated B10.RIII B cells (1 × 104 to 5 X l0 p) or with 3,300-rad irradiated B10.R III low density cells were ineffective at stimulating [~H]thymidine incorporation by the B10.S(9R) B cells (Fig. 3) . In the same experiment, B10.S(9R) B cells co-cultured with irradiated B10.A B cells, 11.4 T cells, and GAT were strikingly stimulated. Indeed, 1 x 10 4 irradiated B10.A B cells were superior to 5 × 10 ~ irradiated B 10.RIII B cells in causing 11.4 T cells to stimulate B10.S(9R) B cells to enter S phase (Fig. 3) . This difference in the capacity to cause 11.4 T cell-dependent stimulation of B10.S(9R) B cells is much greater than the two-to threefold difference in the proliferative responses of B10.A and B10.R III B cells stimulated by 11.4 T ceils (Fig. 4) .
This (Fig. 5) .
Discussion
These experiments demonstrate the ability of T cell lines to cause many, if not all, resting B cells to enter G~ phase, proliferate, and secrete large amounts of antibody. These T cell-mediated responses were displayed by B cells of different MHC genotypes, provided that the T cells were optimally stimulated by antigen in the context of APC bearing syngeneic Ia molecules. For this purpose, syngeneic resting B cells were as efficient at antigen presentation as were populations enriched for macrophages and dendritic cells (19) . The response of allogeneic B cells were comparable to these of syngeneic B cells, provided substantial numbers of syngeneic B cells or macrophages were present, presumably to serve as APC for the T cells, and provided that high concentrations of antigen were used to stimulate the T cells (Fig. 5) .
Resting B cells could be driven to proliferate by most of the IL-2-secreting T cell hybridomas tested, by all of the tested T cell lines including cloned lines propagated by alternating cycles of growth and rest, and by one T cell line isolated by cloning in soft agar, followed by continuous growth on IL-2 without antigen or accessory cells (28) . Therefore, the ability of in vitro T cells lines and hybridomas to stimulate B cells as reported here is not a rare or uncommon property of T cells, but rather seems to be typical of many in vitro T cells maintained by different growth techniques.
Recent work with T cell-derived lymphokines such as BSF-pl (9, 35) and other growth and differentiation factors (36) (37) (38) (39) (40) suggests possible mechanisms by which the T cells used in this work might have caused some of the responses observed. Previous experiments had not revealed, however, the existence of a T cell-derived factor capable of acting on resting B cells and stimulating them to enter and progress through Gl phase of the cell cycle. Anti-u previously has been shown to perform this activation step (4), suggesting that some antigens with the ability to cross-link mIg might be able to do this as well. The experiments presented in this paper clearly demonstrate that T cells can stimulate this activation step under the appropriate circumstances, without requirement for occupancy of B cell antigen receptors or interaction with B cell Ia molecules. Synergy was seen between antigen-stimulated 11.4 T cells and anti-~ in the stimulation of B cell proliferation (Table II) A similar argument could explain apparent MHC restriction in antigen-specific antibody responses. When high doses of antigen are used (e.g. 100 #g/ml), many cells in the culture can present antigen and the magnitude of T cell response is great, leading to production of large amounts of activating factor(s) and to nonrestricted B cell activation. On the other hand, when lower antigen concen-trations are used one might expect that only the antigen-specific B cell would bind sufficient antigen, via its membrane immunoglobulin, to act as an antigenpresenting B cell. Such a possibility has been graphically illustrated by Hedrick and Schwartz (44) , who found that T cells specific for IgG2a allotypes could respond to a 1,000-fold lower concentration of antigen if the IgG2a was specific for and reacted with molecules on the surface of APC. Alternatively, the principal APC in such cultures may be macrophages and other Ia-bearing cells, such as dendritic cells. Indeed, in most experiments of this type, responses are reported to be macrophage dependent. Under such circumstances, when low antigen concentrations are used, each T cell is stimulated relatively poorly (i.e., by APC bearing small amounts of antigen). Such T cells would be expected to produce small amounts of activating factor(s). Syngeneic B cells, specific for the antigen that stimulated the T cells, would be bound by the responding T cells because those T cells would recognize the antigen and the restriction elements on the B cells. This would lead to activation of antigen-specific syngeneic B cells. In contrast, neither allogeneic antigen-specific B cells nor syngeneic non-antigenspecific B cells would interact with the T cells. The former would fail to interact because, although they would have bound antigen to their receptors, they do not display a restriction element for which the T cells were co-specific. The latter cells would fail to interact with T cells because, although they express the proper restriction elements, they fail to capture sufficient antigen on their membrane when low concentrations are used since their receptors are not specific for that antigen. Of course, allogeneic B cells lacking receptors for the antigen in question would present neither the appropriate restriction element nor the proper antigen. This would lead to a situation in which antigen-specific B cells bearing class II molecules syngeneic to the T cells would be preferentially activated; that is, to an MHC-restricted T celI-B cell interaction. Furthermore, in hapten-carrier systems in which carrier-specific T cells are used and anti-hapten antibody responses are measured, cellular interactions could be achieved only if the hapten and carrier were linked to one another.
The results of Asano et al. (34) fit this scenario fairly well. They found that stimulation of B cells by cloned in vitro T cell lines was not MHC restricted at high antigen concentrations, but was restricted and required hapten-carrier linkage at low antigen concentrations. An apparent discrepancy between our results and theirs is that Asano et al. (34) found that xid B cells could not be stimulated to become hapten-specific antibody-producing cells in a non-MHCrestricted manner when high antigen concentrations were used. In our experiments, allogeneic xid B cells proliferated -50% as well as did allogeneic B cells from normal mice in the presence of irradiated syngeneic B cells, 11.4 T cells, and antigen. A possible reason for this difference may be that antigen-specific responses in cultures receiving high antigen concentrations may require very substantial relative expansion of hapten-specific clones. Receptor cross-linkage by antigen could cause such expansion by making B cells sensitive to BSF-pl; xid B cells fail to proliferate in response to anti-~ together with BSF-pl, suggesting that they would not display such clonal expansion. This could lead to the striking difference reported in antigen-specific antibody responses of normal and xid B cells when high antigen doses are used. By contrast, we would predict that in such systems measurement of total Ig production would reveal little or no difference between normal and xid B cells because receptor cross-linked stimulation of clonal expansion would play a lesser role in total Ig synthesis in such cultures.
Although nonspecific activating factors produced by stimulated T cells may explain many examples of MHC-restricted B cell stimulation, it does not rule out the possibility that activation mediated by truly MHC-restricted mechanisms does exist. Indeed, there are reports of MHC-restricted helper factors (45, 46) and allogeneic effect factor (AEF) has many of the properties one would expect of an MHC-restricted factor (47) . Such factors are believed to act early in the B cell response, although that has not been demonstrated directly. Stimulation of B cells by some helper T cells may involve this putative MHC-restricted event, whereas other T cells, such as the in vitro lines and hybridomas used in this work, may be capable of releasing additional factors that bypass this requirement. The apparent MHC-restricted stimulation of B cells by 11.4 T cells responding to B10.RIII B cells could be due to secretion of an MHC-restricted factor, but as we have already pointed out, this phenomenon may be explained by the action of nonspecific factors.
Pathway of B Cell Responses.
The results presented in this paper and the results of others suggest a more complicated view of B cell responses than is generally discussed. Each of the various events involved in causing a resting B cell to enter the cell cycle, to proliferate and to differentiate into an antibody-secreting cell, may be triggered by several different stimuli. For example, entry into G1 phase is clearly stimulated by anti-u, presumably by some antigens, and is also stimulated in an MHC-unrestricted manner by antigen-stimulated T cell lines as demonstrated here. This is also the step in the B cell response postulated to be controlled in an MHC-restricted manner, based upon experiments showing that large B cells from the spleen no longer need this signal (2). Since both anti-t~ and antigenstimulated T cells can each cause virtually all resting B cells to enlarge, these two signals would seem to represent parallel pathways of activation. If an MHCrestricted signal does exist, it may represent a third parallel pathway. Although B cells may be activated by each of these stimuli, it is not clear whether the consequences of the activation process is the same in each case. Detailed examination of the properties of G1 phase B cells resulting from distinct stimuli will be required to determine the equivalence or lack of equivalence of the various stimuli.
The value of experiments such as the ones reported here is to point out the nature of the steps in the B cell response caused by stimulated helper T cells and thereby suggest the existence of presently unknown lymphokines with novel functions. Based on these experiments, we propose the existence of a B cell activating factor that will act on a resting B cell and cause it to enter G~ phase in an MHC-unrestricted manner.
Summary
Resting B lymphocytes are activated, proliferate, and differentiate into antibody-secreting cells when cultured with long-term lines of major histocompatibility complex (MHC)-restricted, antigen-specific T cell in the presence of the antigen for which the T cells are specific. Under optimal conditions, essentially all B cells are activated and ~35% enter S phase in the absence of antigens for which the B cells are specific. Activation and proliferation are observed in cells from both normal mice and mice with the xid-determined immune defect. Highly purified B cells bearing Ia molecules for which the T cells are "cospecific" can present antigen to T cells with the resulting T cell stimulation leading to the activation and proliferation of the antigen-presenting B cells. However, B cells that do not bear Ia molecules for which the T cells are cospecific are also activated and proliferate if antigen and a source of antigen-presenting B ceils or macrophage-rich cells of proper histocompatibility type are present. Thus, resting B cells, both normal and "xid', can be activated by non-MHC restricted factors without receptor cross-linkage. Experiments are presented that support the concept that local production and action of such unrestricted activating factors may be responsible for the MHC-restriction of T cell-B cell interaction seen in many circumstances.
